Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

10-year impact assessment of the UK’s Efficacy and Mechanism Evaluation programme

Publication date: 21 January 2022 | Report language: EN

The UK government funds scientists to conduct research to develop better ways to support health,
treat diseases and improve long-term care for patients. The Efficacy and Mechanism Evaluation
programme, a partnership between the UK Medical Research Council and National Institute for Health
Research, enables scientists to find out if and how a promising new approach might work in practice.
Between 2009 and 2018, the Efficacy and Mechanism Evaluation programme funded 145 research
projects with a total of £175.5M. To understand the programme’s impact, what worked well and where
improvements might be needed, an independent evaluation was carried out.

Researchers from Technopolis Group (Brighton, UK) and Ipsos MORI (London, UK) looked carefully at
data available about the Efficacy and Mechanism Evaluation programme and projects, and gathered
new information from project leads and experts involved in health research. These researchers found
that the programme supports important research that tests whether or not a treatment or approach
can work. Most Efficacy and Mechanism Evaluation projects looked at treatments that can benefit
patients or save costs in the health service but that are of little interest to industry (e.g. using a
cheap existing drug to treat a disease or patient group that it is not yet used for). At the time of the
evaluation, 43 projects were complete, of which seven had provided findings that informed decisions
on how health care should be delivered.

Efficacy and Mechanism Evaluation projects researched treatments across many health needs that
exist in the UK, but some problems that affect many people were investigated by few or no projects.
To steer scientists towards areas of need, the National Institute for Health Research sometimes
describes the research it is looking for when inviting proposals. However, many of these calls
for proposals do not lead to funded projects. Understanding the reasons for this may identify how
research in these areas can be better supported.

The evaluation makes recommendations for how the Efficacy and Mechanism Evaluation programme
can be improved to increase its impact or make it easier for scientists to carry out research.